ML
IRWD icon

McAdam LLC’s Ironwood Pharmaceuticals IRWD Stock Holding History

McAdam LLC’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-27,294
Closed -$40.1K – 382
2025
Q1 		$40.1K Buy
+27,294
New +$65K ﹤0.01% 338
2018
Q4 		– Sell
-36
Closed -$1K – 322
2018
Q3 		$1K Hold
36
– – ﹤0.01% 586
2018
Q2 		$1K Buy
+36
New +$533 ﹤0.01% 558

Other funds holding IRWD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

McAdam LLC's IRWD Position: Q2 2025 in Review

McAdam LLC sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2025, closing a stake of 27,294 shares — an estimated $40.1K sold.

McAdam LLC first reported a position in IRWD in Q2 2018 and held it in 3 quarters. The position peaked at $40.1K in Q1 2025. 155 funds tracked by Wall St. Rank hold IRWD as of Q2 2025.

  • McAdam LLC reported no remaining Ironwood Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • McAdam LLC sold 27,294 Ironwood Pharmaceuticals shares in Q2 2025, an estimated $40.1K.
  • McAdam LLC first reported a position in Ironwood Pharmaceuticals in Q2 2018 and held it in 3 quarters.
  • McAdam LLC's Ironwood Pharmaceuticals position peaked at $40.1K in Q1 2025.
  • 155 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2025.

Based on McAdam LLC's 13F filing for Q2 2025, filed 15 Jul 2025.